Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 8-K Event Results of operations · Regulation FD disclosure
  2. 8-K Event Material agreement · Regulation FD disclosure
  3. 4 Grant or award Director acquired 12,800 shares (grant or award)
  4. 4 Grant or award Director acquired 12,800 shares (grant or award)
  5. 4 Grant or award Director acquired 12,800 shares (grant or award)
  6. 4 Grant or award Director acquired 12,800 shares (grant or award)
  7. 4 Grant or award Director acquired 12,800 shares (grant or award)
  8. 4 Grant or award Director acquired 12,800 shares (grant or award)
  9. 4 Grant or award Director acquired 12,800 shares (grant or award)
  10. 8-K Event Shareholder vote results
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations · Regulation FD disclosure
  13. ARS Other Annual Report to Security Holders
  14. DEFA14A Proxy Proxy Materials
  15. DEF 14A Proxy Proxy Statement
  16. SCHEDULE 13D/A Stake Beneficial Ownership Report
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 10-K Report Annual Report
  19. 8-K Event Results of operations · Regulation FD disclosure
  20. 4 Planned sale CFO & Chief Business Officer sold 33,266 shares at an average $1.70 ($56,620)

Page 7 of 19 · 365 filings